Concepedia

Chloé Herledan

CH

Statistics

Publications

5

Citations

98

H-Index

5

Active since

2021

Affiliations

Hospices Civils de Lyon(Current)

Université Claude Bernard Lyon 1

Centre de Recherche en Cancérologie de Lyon

Hôpital Lyon Sud

Chloé Herledan is an author at Hospices Civils de Lyon specializing in clinical pharmacology, anticancer drug interactions, and pharmacology.

ORCID

Publications per year

2021–2023

5

Publications

5

Real-life drug–drug and herb–drug interactions in outpatients taking oral anticancer drugs: comparison with databases

H. Prely, Chloé Herledan, A.-G. Caffin et al. · Journal of Cancer Research and Clinical Oncology · 2021 · 48 citations · Full text

, , +16

Thromboembolic events and thromboprophylaxis associated with immunomodulators in multiple myeloma patients: a real-life study

Vincent Leclerc, Lionel Karlin, Chloé Herledan et al. · Journal of Cancer Research and Clinical Oncology · 2021 · 19 citations · Full text

, , +16

Medication assessment in older adults with cancer – Current practices in clinical pharmacy

Darren J. Walsh, Kavita Kantilal, Chloé Herledan et al. · Journal of Geriatric Oncology · 2023 · 11 citations · Full text

, , +17

Immunosuppression medication adherence after allogeneic hematopoietic stem cell transplant: Impact of a specialized clinical pharmacy program

Florent Charra, Michaël Philippe, Chloé Herledan et al. · Journal of Oncology Pharmacy Practice · 2021 · 10 citations

, , +16

Clinical impact and cost‐saving analysis of a comprehensive pharmaceutical care intervention in older patients with cancer

Chloé Herledan, C. Falandry, Laure Huot et al. · Journal of the American Geriatrics Society · 2023 · 10 citations · Full text

, , +17

1–5 of 5